Nephrogenic Systemic Fibrosis Lawyers
Are you looking for legal assistance regarding NSF or some other type of Gadolinium-induced sickness in The USA? If so, fill in the form at the bottom of this page, to contact an experienced NSF law firm in The USA. LegalView’s NSF site contains a wide range of resources regarding NSF and NSF Law Suits -- use the links on the left side of this page. You’ll find information about which companies manufactured Gadolinium and which medical procedures can put you particularly at risk; resources to help you if you are sick with NSF, and more. But if you think you may have a NSF case, contact a LegalView attorney now, using the form below.
You can find excerpts from some of our informative content here: See below for a few examples of our Nephrogenic Systemic Fibrosis related content:
Opexa Therapeutics Completes Patient Enrollment in Phase IIb Trial of ... - MSN Newsfeeds
Forbes - Food and Drug Administration (FDA), will receive 52 weeks of treatment and will undergo safety and efficacy assessments using primary criterion of gadolinium-enhancing lesions and secondary criterion of annualized relapse rate. The Company will ... [click for more]
Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference - News Articles
LOUISVILLE, Colo., Dec. 5 /prnewswire-firstcall/ -- Replidyne, Inc. announced today that President and Chief Executive Officer Kenneth J. Collins will participate on the New and Powerful Anti-infectives panel at the RBC Capital Markets 2007 Healthcare Conference. The panel discussion ... [click for more]
Nanotechnology Now - Press Release: "Luna nanoWorks' Next-Generation MRI Contrast Agent Breakthrough Published in Journal of Medicinal Chemistry" - News Articles
Researchers from Luna nanoWorks, a division of Luna Innovations Incorporated, and the Washington University School of Medicine co-authored a paper titled "Hydrochalarones: A Novel Endohedral Metallofullerene Platform for Enhancing Magnetic Resonance Imaging Contrast" that was published in the peer-reviewed Journal ... [click for more]



